Literature DB >> 21472044

The role of oncogenes in gastrointestinal cancer.

Emmanouil P Pappou1, Nita Ahuja.   

Abstract

Oncogene research over the last century has been one of the major advances in understanding the molecular biology of malignant disease. Oncogenes are a structurally and functionally heterogeneous group of genes, whose protein products act pleiotropically and affect multiple complex regulatory cascades within the cell. They regulate cell proliferation, growth, and differentiation, as well as control of the cell cycle and apoptosis. The products of oncogenes include growth factors, growth factor receptors, signal transducers, transcription factors, and apoptosis regulators, as well as chromatin remodelers. Several distinct mechanisms have been described for the conversion of proto-oncogenes to active oncogenes. Quantitative forms of oncogene activation include multiplication (gene amplification) or translocation to an active chromatin domain that brings a growth-regulatory gene under the control of a different promoter, causing inappropriate expression of the gene. Qualitative forms include either point mutations or the production of a novel product from a chimeric gene. Further understanding of the molecular mechanisms by which oncogenes regulate normal development and tumorigenesis may lead to novel concepts in the diagnosis and treatment of cancer in humans. In this review, we focus on the role of selected oncogenes in gastrointestinal cancer.

Entities:  

Year:  2010        PMID: 21472044      PMCID: PMC3047044     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


  263 in total

1.  Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.

Authors:  W S Samowitz; K Curtin; D Schaffer; M Robertson; M Leppert; M L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

4.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

5.  Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

Authors:  Y Ito; N Matsuura; M Sakon; E Miyoshi; K Noda; T Takeda; K Umeshita; H Nagano; S Nakamori; K Dono; M Tsujimoto; M Nakahara; K Nakao; N Taniguchi; M Monden
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

6.  [Detection of K-ras point mutations in the stool of patients with colorectal tumors].

Authors:  Y Kohata
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1996-06

7.  Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

Authors:  M Tada; M Omata; S Kawai; H Saisho; M Ohto; R K Saiki; J J Sninsky
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

8.  Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; T Komeda; R Kita; T Sando; M Furukawa; M Amenomori; I Shibagaki; K Nakao; M Ikenaga
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

9.  KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin.

Authors:  Jerzy Lasota; Janusz Kopczynski; Maarit Sarlomo-Rikala; Regine Schneider-Stock; Tomasz Stachura; Radzislaw Kordek; Michal Michal; Carsten Boltze; Albert Roessner; Jerzy Stachura; Markku Miettinen
Journal:  Hum Pathol       Date:  2003-12       Impact factor: 3.466

10.  Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.

Authors:  Charles T Miller; Justin R Moy; Lin Lin; Matthew Schipper; Daniel Normolle; Dean E Brenner; Mark D Iannettoni; Mark B Orringer; David G Beer
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

View more
  3 in total

1.  Overexpression of Nedd9 is a prognostic marker of human gastric cancer.

Authors:  Qi Zhang; Huiju Wang; Yingyu Ma; Jun Zhang; Xujun He; Jie Ma; Zhong-Sheng Zhao
Journal:  Med Oncol       Date:  2014-06-07       Impact factor: 3.064

Review 2.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

3.  Identification of homogeneously staining regions in leukemia patients.

Authors:  Mohammad Heydarian Moghadam; Abolfazl Movafagh; Mirdavood Omrani; Kiandokht Ghanati; Mehrdad Hashemi; Farhikhteh Poursafavi; Hossein Darvish; Davood Zare Abdolahi; Milad Gholami; Mohammad Reza Heidari Rostamy; Shamsi Safari; Leyla Haghnejad; Reyhaneh Darehgazani; Niloofar Safavi Naeini; Mehdi Ghandehari Motlagh; Davar Amani
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.